Alyeska Investment Group’s Biotech Acquisition Company Class A Ordinary Shares BIOT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q3
Sell
-150,000
Closed -$1.49M 598
2022
Q2
$1.49M Hold
150,000
0.02% 433
2022
Q1
$1.48M Hold
150,000
0.02% 460
2021
Q4
$1.48M Hold
150,000
0.02% 478
2021
Q3
$1.46M Hold
150,000
0.02% 550
2021
Q2
$1.45M Buy
150,000
+60,000
+67% +$580K 0.02% 558
2021
Q1
$875K Buy
+90,000
New +$875K 0.01% 596